The table below shows REPLIGEN CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$194.25M
$188.81M
$182.37M
$169.17M
$154.87M
$158.84M
Cost of revenue
$85.97M
$88.29M
$91.22M
$77.80M
$77.38M
$77.31M
Gross profit
-
-
-
-
-
-
R&D
$14.46M
$14.18M
$13.96M
$12.11M
$9.71M
$10.57M
RGEN annual revenue (10-K history)
REPLIGEN CORP reported annual revenue of $738.26M for fiscal year 2025. That is up 16.4% from $634.44M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $104.54M (FY 2016) to $738.26M. Figures come from the company's audited annual reports as filed with the SEC.
